Welcome to the ESID 2021 Online Meeting Interactive Programme

The meeting will officially run on Central European Summer Time (CEST)
To convert the meeting times to your local time Click Here

Icons Legend:  - Live Session   - Pre-recorded with Live Q&A

Displaying One Session

View

Oral Presentation Session - B/Plasma Cell Depleting Therapies No.2

Session Type
Oral Presentations
Date
Tue, 28.09.2021
Session Time
11:15 - 12:30
Room
Oral Presentations Hall 2
Chair(s)
  • Fabio Candotti (Switzerland)
  • Raffaele Badolato (Italy)
Session Icon
On Demand with Live Q&A

Introduction

Presenter
  • Fabio Candotti (Switzerland)
Lecture Time
11:15 - 11:17

PILOT STUDY: NAIVE B CELL FUNCTIONALITY IN POST RITUXIMAB PATIENTS WITH SECONDARY HYPOGAMMAGLOBULINEMIA.

Presenter
  • Lucía Del Pino Molina (Spain)
Lecture Time
11:17 - 11:25

IMMUNOGLOBULIN MONITORING IN A PEDIATRIC AUTOIMMUNE DISEASE COHORT TREATED WITH RITUXIMAB

Presenter
  • Yousuf Karim (Qatar)
Lecture Time
11:25 - 11:33

IMPAIRED REGULATORY B-CELL (BREG) IN HUMAN LRBA DEFICIENCY SYNDROME

Presenter
  • Celia Kaffenberger (Germany)
Lecture Time
11:33 - 11:41

CHARACTERIZING CHRONIC T CELL ACTIVATION IN IMMUNE DYSREGULATION IN COMMON VARIABLE IMMUNODEFICIENCY

Presenter
  • Helen L. Leavis (Netherlands)
Lecture Time
11:41 - 11:49

SECONDARY IMMUNODEFICIENCY AND COMPLICATIONS DUE TO RITUXIMAB TREATMENT IN CHILDREN WITH GIANT CELL HEPATITIS ASSOCIATED WITH AUTOIMMUNE HEMOLYTIC ANEMIA- A SINGLE CENTER EXPERIENCE.

Presenter
  • Maja A. Klaudel-Dreszler (Poland)
Lecture Time
11:49 - 11:57

Live Q&A

Lecture Time
11:57 - 12:22